REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Oculomedica Sp. z o.o. (Poland)

Main Activities: Ambulatory Health Care Services
Full name: Oculomedica Sp. z o.o. Profile Updated: May 09, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Oculomedica Sp. z o.o is a private medical center specializing in comprehensive eye care services. The company offers eye diagnostics, surgical procedures, laser therapy of retina and glaciers, removal operations, and injections for age-related flame degeneration, diabetes, and other diseases. Oculomedica has established a Research and Development Center for developing new methods of visual diagnosis and improving behavioral algorithms in the field of ophthalmology.

Headquarters
Ul. Jagiellonska 81
Bydgoszcz; Kujawsko-Pomorskie; Postal Code: 85-027

Contact Details: Purchase the Oculomedica Sp. z o.o. report to view the information.

Website: http://www.oculomedica.pl

Basic Information
Total Employees:
Purchase the Oculomedica Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Oculomedica Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Oculomedica Sp. z o.o. report to view the information.
Incorporation Date:
August 03, 2010
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Oculomedica Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
42.29%▲
Total operating revenue
47.81%▲
Operating profit (EBIT)
77.27%▲
EBITDA
120.8%▲
Net Profit (Loss) for the Period
75.56%▲
Total assets
112.63%▲
Total equity
30.35%▲
Operating Profit Margin (ROS)
4.9%▲
Net Profit Margin
4.74%▲
Return on Equity (ROE)
6%▲
Debt to Equity Ratio
47.84%▲
Quick Ratio
2.94%▲
Cash Ratio
1.73%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo